JP2020512302A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020512302A5 JP2020512302A5 JP2019545923A JP2019545923A JP2020512302A5 JP 2020512302 A5 JP2020512302 A5 JP 2020512302A5 JP 2019545923 A JP2019545923 A JP 2019545923A JP 2019545923 A JP2019545923 A JP 2019545923A JP 2020512302 A5 JP2020512302 A5 JP 2020512302A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- compound according
- alkyl
- group
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CCC(C(C)C)C1C*CC1 Chemical compound CCC(C(C)C)C1C*CC1 0.000 description 2
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022155899A JP7381684B2 (ja) | 2017-03-10 | 2022-09-29 | 遊離可能コンジュゲート |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762469989P | 2017-03-10 | 2017-03-10 | |
| US62/469,989 | 2017-03-10 | ||
| US201762564820P | 2017-09-28 | 2017-09-28 | |
| US62/564,820 | 2017-09-28 | ||
| PCT/IB2018/051579 WO2018163131A1 (en) | 2017-03-10 | 2018-03-10 | Releasable conjugates |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022155899A Division JP7381684B2 (ja) | 2017-03-10 | 2022-09-29 | 遊離可能コンジュゲート |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020512302A JP2020512302A (ja) | 2020-04-23 |
| JP2020512302A5 true JP2020512302A5 (https=) | 2021-04-22 |
| JP7152408B2 JP7152408B2 (ja) | 2022-10-12 |
Family
ID=61764062
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019545923A Active JP7152408B2 (ja) | 2017-03-10 | 2018-03-10 | 遊離可能コンジュゲート |
| JP2022155899A Active JP7381684B2 (ja) | 2017-03-10 | 2022-09-29 | 遊離可能コンジュゲート |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022155899A Active JP7381684B2 (ja) | 2017-03-10 | 2022-09-29 | 遊離可能コンジュゲート |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11786599B2 (https=) |
| EP (2) | EP4011396A1 (https=) |
| JP (2) | JP7152408B2 (https=) |
| KR (1) | KR20190125310A (https=) |
| CN (1) | CN110545850A (https=) |
| AU (2) | AU2018231832A1 (https=) |
| BR (1) | BR112019017103A2 (https=) |
| CA (1) | CA3051173A1 (https=) |
| DK (1) | DK3592393T3 (https=) |
| SI (1) | SI3592393T1 (https=) |
| WO (1) | WO2018163131A1 (https=) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4011396A1 (en) | 2017-03-10 | 2022-06-15 | QuiaPEG Pharmaceuticals AB | Releasable conjugates |
| TW202003044A (zh) | 2018-03-09 | 2020-01-16 | 瑞典商奎亞培格製藥公司 | 可釋放之抗體結合物 |
| AU2019340472A1 (en) * | 2018-09-12 | 2021-04-01 | Quiapeg Pharmaceuticals Ab | Releasable GLP-1 conjugates |
| CN111175387B (zh) * | 2018-11-13 | 2022-06-07 | 成都康弘药业集团股份有限公司 | 一种米那普仑异构体的检测方法 |
| US10768173B1 (en) | 2019-09-06 | 2020-09-08 | Element Biosciences, Inc. | Multivalent binding composition for nucleic acid analysis |
| CN112168820B (zh) * | 2019-07-05 | 2023-09-29 | 中国科学院生物物理研究所 | SRCAP ATPase抑制剂在结直肠癌治疗中的应用 |
| US11287422B2 (en) | 2019-09-23 | 2022-03-29 | Element Biosciences, Inc. | Multivalent binding composition for nucleic acid analysis |
| KR102398574B1 (ko) | 2019-10-10 | 2022-05-13 | 주식회사 엘지에너지솔루션 | 전지 모듈 및 이를 포함하는 전지 팩 |
| CN110946844A (zh) * | 2019-12-11 | 2020-04-03 | 正大制药（青岛）有限公司 | 一种含有艾地骨化醇的复方控释制剂 |
| WO2021155427A1 (en) * | 2020-02-03 | 2021-08-12 | Snoretox Pty Ltd | Composition and method |
| CN113456824B (zh) * | 2020-03-31 | 2023-03-31 | 四川大学华西医院 | 一种抗肿瘤载药纳米复合材料 |
| WO2022029178A1 (en) | 2020-08-05 | 2022-02-10 | Ascendis Pharma A/S | Conjugates comprising reversible linkers and uses thereof |
| CN112138170B (zh) * | 2020-09-28 | 2022-05-20 | 广东药科大学 | 一种预防顺铂药源性聋的缀合物及其制备方法和应用 |
| CN112316156B (zh) * | 2020-10-27 | 2022-03-15 | 四川大学 | 具抗氧化和抗菌性的胶原蛋白修复膜、其制备方法及应用 |
| CN112402620A (zh) * | 2020-12-07 | 2021-02-26 | 南开大学 | 肿瘤微环境还原响应性的纳米药物及其制备方法 |
| CN112457383B (zh) * | 2020-12-16 | 2022-06-17 | 阿南达 | 一种多肽、制备方法及其医药用途 |
| CN112516285B (zh) * | 2020-12-18 | 2022-09-02 | 中南大学 | 一种预防或治疗缺血/再灌注损伤的药物组合物及应用 |
| CN112574272B (zh) * | 2020-12-25 | 2021-09-21 | 中国医学科学院药用植物研究所 | 一种灵芝酸a衍生物的制备及其应用 |
| CN114478800B (zh) * | 2021-02-05 | 2022-10-11 | 华南理工大学 | 基于血清白蛋白的融合蛋白、纳米组装体及其制备方法和应用 |
| CN112999196B (zh) * | 2021-03-03 | 2023-04-28 | 西安医学院 | 用于长效稳定释放的吗替麦考酚酯纳米制剂及其制备方法 |
| CN113133989B (zh) * | 2021-03-09 | 2023-04-25 | 西安医学院 | 一种用于抗结核药物利福平的长效制剂及制备方法 |
| CN114617876B (zh) * | 2022-01-28 | 2023-04-07 | 四川大学华西医院 | 一种抗肿瘤联合用药物 |
| CN114886817B (zh) * | 2022-06-02 | 2023-06-27 | 杭州配方师科技有限公司 | 一种弗来歇氏柳叶菜和酵母菌锌发酵复合物、制备方法及应用 |
| EP4539887A1 (en) * | 2022-06-16 | 2025-04-23 | Merck Sharp & Dohme LLC | Interleukin-2 prodrugs |
| AU2023325064A1 (en) | 2022-08-15 | 2025-03-06 | Element Biosciences, Inc. | Spatially resolved surface capture of nucleic acids |
| CN116333047A (zh) * | 2022-12-22 | 2023-06-27 | 四川大学华西医院 | 一种抗菌肽及其制备方法 |
| CN119331240B (zh) * | 2023-07-19 | 2026-01-02 | 南京大学 | 一种苯并环辛炔-聚乙二醇修饰的常山酮及其制备方法和应用 |
| KR102623104B1 (ko) * | 2023-08-23 | 2024-01-11 | 에프아이씨씨주식회사 | 보툴리눔톡신 결합체와 줄기세포 엑소좀 복합체를 유효성분으로 함유하는 피부 재생 및 주름 개선용 화장료 조성물 및 그의 제조 방법 |
| WO2025257419A1 (en) * | 2024-06-13 | 2025-12-18 | 4Moving Biotech | Glp-1 receptor agonist compounds for treating a proliferative synovial disorder |
| CN118415977B (zh) * | 2024-07-03 | 2024-08-23 | 山东新时代药业有限公司 | 一种米力农注射剂及其用途 |
| CN119709677B (zh) * | 2024-10-28 | 2025-05-06 | 皖西学院 | 一种糖基转移酶及其在制备金线莲苷中的应用 |
| CN119613558B (zh) * | 2024-12-12 | 2025-08-15 | 东北农业大学 | 一种抗磺胺嘧啶纳米抗体及其应用 |
| CN120531651B (zh) * | 2025-07-29 | 2025-09-30 | 清枫链食苏打饮品(吉林)有限公司 | 人参提取物、制备方法及其在美白嫩肤祛皱产品中的应用 |
Family Cites Families (68)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US200130A (en) * | 1878-02-12 | Improvement in joining sheet metal to wire-cloth for the construction of fly-traps | ||
| US4647447A (en) | 1981-07-24 | 1987-03-03 | Schering Aktiengesellschaft | Diagnostic media |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US5208020A (en) | 1989-10-25 | 1993-05-04 | Immunogen Inc. | Cytotoxic agents comprising maytansinoids and their therapeutic use |
| US5304121A (en) | 1990-12-28 | 1994-04-19 | Boston Scientific Corporation | Drug delivery system making use of a hydrogel polymer coating |
| ES2149768T3 (es) | 1992-03-25 | 2000-11-16 | Immunogen Inc | Conjugados de agentes enlazantes de celulas derivados de cc-1065. |
| US5395619A (en) | 1993-03-03 | 1995-03-07 | Liposome Technology, Inc. | Lipid-polymer conjugates and liposomes |
| US5886026A (en) | 1993-07-19 | 1999-03-23 | Angiotech Pharmaceuticals Inc. | Anti-angiogenic compositions and methods of use |
| US5637684A (en) | 1994-02-23 | 1997-06-10 | Isis Pharmaceuticals, Inc. | Phosphoramidate and phosphorothioamidate oligomeric compounds |
| US6211244B1 (en) | 1994-10-21 | 2001-04-03 | Nps Pharmaceuticals, Inc. | Calcium receptor-active compounds |
| US6099562A (en) | 1996-06-13 | 2000-08-08 | Schneider (Usa) Inc. | Drug coating with topcoat |
| US6267958B1 (en) | 1995-07-27 | 2001-07-31 | Genentech, Inc. | Protein formulation |
| US5817856A (en) | 1995-12-11 | 1998-10-06 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Radiation-protective phospholipid and method |
| US5830600A (en) * | 1996-05-24 | 1998-11-03 | Sri International | Nonflammable/self-extinguishing electrolytes for batteries |
| JPH10175987A (ja) | 1996-12-13 | 1998-06-30 | Nof Corp | 重合性基含有有機リン酸エステル化合物およびその製造方法 |
| US6180095B1 (en) | 1997-12-17 | 2001-01-30 | Enzon, Inc. | Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents |
| US5922897A (en) | 1998-05-29 | 1999-07-13 | Xerox Corporation | Surfactant processes |
| JP2000212191A (ja) * | 1999-01-26 | 2000-08-02 | Sankyo Co Ltd | リン酸誘導体 |
| US20030165849A1 (en) | 2000-11-28 | 2003-09-04 | Biliang Zhang | Methods and reagents for introducing a sulfhydryl group into the 5'-terminus of RNA |
| US6320041B1 (en) | 2001-04-13 | 2001-11-20 | Trilink Biotechnologies, Inc. | Pre-activated carbonyl linkers for the modification of oligonucleotides |
| US6743905B2 (en) | 2001-04-16 | 2004-06-01 | Applera Corporation | Mobility-modified nucleobase polymers and methods of using same |
| CA2446904A1 (en) | 2001-05-24 | 2003-04-03 | Alexza Pharmaceuticals, Inc. | Delivery of drug esters through an inhalation route |
| US20100240730A1 (en) | 2002-02-20 | 2010-09-23 | Merck Sharp And Dohme Corp. | RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA) |
| US20040062748A1 (en) | 2002-09-30 | 2004-04-01 | Mountain View Pharmaceuticals, Inc. | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof |
| WO2004073620A2 (en) | 2003-02-14 | 2004-09-02 | Quanta Biodesign, Ltd | The selective and specific preparation of discrete peg compounds |
| US7498298B2 (en) | 2003-11-06 | 2009-03-03 | Seattle Genetics, Inc. | Monomethylvaline compounds capable of conjugation to ligands |
| US20070276139A1 (en) | 2004-02-10 | 2007-11-29 | Quanlai Song | Substituted Pixyl Protecting Groups for Oligonucleotide Synthesis |
| MXPA06010782A (es) * | 2004-03-23 | 2007-03-28 | Complex Biosystems Gmbh | Ligador de profarmaco. |
| JP2008501765A (ja) | 2004-06-11 | 2008-01-24 | ノボ ノルディスク アクティーゼルスカブ | Ｇｌｐ−１アゴニストを用いた薬剤誘発性肥満の中和 |
| US20060063147A1 (en) | 2004-09-21 | 2006-03-23 | Chernov Boris K | Omega-amino-PEG-phosphoramidites and conjugates thereof |
| TW200612993A (en) | 2004-10-08 | 2006-05-01 | Alza Corp | Lipopolymer conjugates |
| AU2006304856A1 (en) | 2005-10-21 | 2007-04-26 | Synageva Biopharma Corp. | Glycolated and glycosylated poultry derived therapeutic proteins |
| WO2007055789A2 (en) | 2005-10-31 | 2007-05-18 | Neose Technologies, Inc. | Expression of soluble therapeutic proteins |
| AU2006316903B8 (en) | 2005-11-23 | 2010-10-14 | F. Hoffmann-La Roche Ag | Polynucleotide labelling reagent |
| JP5096363B2 (ja) | 2005-12-16 | 2012-12-12 | ネクター セラピューティックス | Ｇｌｐ−１のポリマ複合体 |
| JP5140824B2 (ja) * | 2006-04-19 | 2013-02-13 | 国立大学法人 東京大学 | リゾホスファチジルスレオニンおよびその誘導体 |
| US7985783B2 (en) | 2006-09-21 | 2011-07-26 | The Regents Of The University Of California | Aldehyde tags, uses thereof in site-specific protein modification |
| TWI409081B (zh) | 2006-11-09 | 2013-09-21 | Alcon Res Ltd | 用於藥物輸送之水不溶性聚合物基質 |
| US20130195888A1 (en) | 2007-11-30 | 2013-08-01 | Abbvie | Ultrafiltration and diafiltration formulation methods for protein processing |
| US8883146B2 (en) | 2007-11-30 | 2014-11-11 | Abbvie Inc. | Protein formulations and methods of making same |
| MX2010008024A (es) | 2008-02-01 | 2010-12-21 | Ascendis Pharma As | Profarmaco que comprende un enlazador que se puede separar por si mismo. |
| TWI451876B (zh) | 2008-06-13 | 2014-09-11 | Lilly Co Eli | 聚乙二醇化之離脯胰島素化合物 |
| JP5642673B2 (ja) | 2008-07-10 | 2014-12-17 | セリナ・セラピユーテイツクス・インコーポレーテツド | 不活性末端基を有するポリオキサゾリン類、保護された開始基から調製されるポリオキサゾリン類及び関連化合物 |
| WO2010033216A1 (en) | 2008-09-19 | 2010-03-25 | Nektar Therapeutics | Polymer conjugates of nesiritide peptides |
| ES2608457T3 (es) | 2009-05-20 | 2017-04-11 | Biomarin Pharmaceutical Inc. | Variantes de péptido natriurético de tipo C |
| EP2459227B1 (en) | 2009-07-31 | 2021-03-17 | Ascendis Pharma A/S | Prodrugs containing an aromatic amine connected by an amide bond to a carrier |
| EP2525830B1 (en) | 2010-01-22 | 2016-05-11 | Ascendis Pharma A/S | Dipeptide-based prodrug linkers for aliphatic amine-containing drugs |
| EP2566335B1 (en) | 2010-05-05 | 2016-06-29 | Prolynx Llc | Controlled release of active compounds from macromolecular conjugates |
| US9387245B2 (en) | 2010-08-06 | 2016-07-12 | University Of Colorado, A Body Corporate | Methods and compositions for the inhibition of fructokinase |
| CA2821411C (en) | 2010-12-13 | 2020-02-25 | Quiapeg Pharmaceuticals Ab | Functionalized polymers |
| AU2012284265B2 (en) * | 2011-07-19 | 2017-08-17 | Wave Life Sciences Ltd. | Methods for the synthesis of functionalized nucleic acids |
| HK1198913A1 (en) | 2011-08-12 | 2015-06-19 | Ascendis Pharma A/S | Carrier-linked prodrugs having reversible carboxylic ester linkages |
| CA3114356C (en) | 2012-06-12 | 2023-08-22 | Quiapeg Pharmaceuticals Ab | Conjugates of biologically active molecules to functionalized polymers |
| EP2910573B1 (en) | 2012-10-19 | 2020-02-19 | Daiichi Sankyo Company, Limited | Antibody-drug conjugate produced by binding through linker having hydrophilic structure |
| JP6701077B2 (ja) * | 2013-12-19 | 2020-05-27 | シアトル ジェネティックス， インコーポレイテッド | 標的化薬物結合体と使用するためのメチレンカルバメートリンカー |
| SG10201811124YA (en) | 2014-06-20 | 2019-01-30 | Abgenomics Int Inc | Her2 antibody-drug conjugates |
| JP6369721B2 (ja) * | 2014-07-04 | 2018-08-08 | 国立大学法人 東京大学 | リゾホスファチジルセリン誘導体 |
| CN104725628B (zh) * | 2014-10-01 | 2018-04-17 | 厦门赛诺邦格生物科技股份有限公司 | 一种含可降解基团的单一官能化支化聚乙二醇、制备方法及其生物相关物质 |
| EP3242689A1 (en) | 2015-01-09 | 2017-11-15 | Ascendis Pharma Growth Disorders A/S | Cnp prodrugs |
| CN107614020A (zh) | 2015-03-18 | 2018-01-19 | 免疫生化公司 | 靶向细胞内肿瘤相关抗原的用于治疗癌症的缀合物 |
| CA2994853C (en) | 2015-08-14 | 2023-06-27 | Rc Biotechnologies, Inc. | Covalent linkers in antibody-drug conjugates and methods of making and using the same |
| LT3400019T (lt) | 2016-01-08 | 2022-12-12 | Ascendis Pharma Growth Disorders A/S | Cnp provaistai su prie žiedo fragmento prijungtu nešikliu |
| MX2018008061A (es) | 2016-01-08 | 2018-08-23 | Ascendis Pharma Growth Disorders As | Profarmacos de peptido natriuretico tipo c (cnp) con porciones portadoras grandes. |
| GB201607827D0 (en) | 2016-05-04 | 2016-06-15 | Bicycle Therapeutics Ltd | Bicyclic peptide-toxin conjugates specific for MT1-MMP |
| EP3565638B8 (en) | 2017-01-06 | 2024-04-10 | BicycleRD Limited | Bicycle conjugate for treating cancer |
| EP4011396A1 (en) * | 2017-03-10 | 2022-06-15 | QuiaPEG Pharmaceuticals AB | Releasable conjugates |
| TW202003044A (zh) | 2018-03-09 | 2020-01-16 | 瑞典商奎亞培格製藥公司 | 可釋放之抗體結合物 |
| AU2019340472A1 (en) * | 2018-09-12 | 2021-04-01 | Quiapeg Pharmaceuticals Ab | Releasable GLP-1 conjugates |
-
2018
- 2018-03-10 EP EP21208889.2A patent/EP4011396A1/en active Pending
- 2018-03-10 SI SI201830575T patent/SI3592393T1/sl unknown
- 2018-03-10 CN CN201880014422.0A patent/CN110545850A/zh active Pending
- 2018-03-10 CA CA3051173A patent/CA3051173A1/en active Pending
- 2018-03-10 AU AU2018231832A patent/AU2018231832A1/en not_active Abandoned
- 2018-03-10 JP JP2019545923A patent/JP7152408B2/ja active Active
- 2018-03-10 DK DK18713014.1T patent/DK3592393T3/da active
- 2018-03-10 BR BR112019017103-7A patent/BR112019017103A2/pt not_active Application Discontinuation
- 2018-03-10 EP EP18713014.1A patent/EP3592393B1/en active Active
- 2018-03-10 KR KR1020197024541A patent/KR20190125310A/ko not_active Ceased
- 2018-03-10 WO PCT/IB2018/051579 patent/WO2018163131A1/en not_active Ceased
- 2018-03-12 US US15/918,944 patent/US11786599B2/en active Active
-
2022
- 2022-09-29 JP JP2022155899A patent/JP7381684B2/ja active Active
-
2023
- 2023-08-15 US US18/234,142 patent/US20230381323A1/en active Pending
-
2024
- 2024-02-26 AU AU2024201279A patent/AU2024201279A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020512302A5 (https=) | ||
| US11629125B2 (en) | Elimination of hepatitis b virus with antiviral agents | |
| JP2015504650A5 (https=) | ||
| ES2963716T3 (es) | Profármacos de nucleósido fosforamidato | |
| Roethle et al. | Identification and optimization of pteridinone Toll-like receptor 7 (TLR7) agonists for the oral treatment of viral hepatitis | |
| JP2020524719A5 (https=) | ||
| JP7710215B2 (ja) | ピロール化合物 | |
| JP2007534636A5 (https=) | ||
| TW201819384A (zh) | 經取代吡<img align="absmiddle" height="18px" width="27px" file="d10999.TIF" alt="其他非圖式 d10999.TIF" img-content="tif" orientation="portrait" inline="yes"></img>化合物及其用途 | |
| JP2020521740A5 (https=) | ||
| JP2006524669A5 (https=) | ||
| JP2017518959A5 (https=) | ||
| JP7648528B2 (ja) | モノマーおよびマルチマー抗ｈｂｖ薬 | |
| JP2016533761A5 (https=) | ||
| RU2016122908A (ru) | Соединения дигидропиримидина и их применение в фармацевтических препаратах | |
| JP2007505138A5 (https=) | ||
| JP2005526857A5 (https=) | ||
| WO2014182643A2 (en) | Methods for treating hcv infection | |
| McGowan et al. | Novel pyrimidine toll-like receptor 7 and 8 dual agonists to treat hepatitis B virus | |
| JP2021535920A5 (https=) | ||
| JP2006509842A5 (https=) | ||
| JP2001335593A5 (https=) | ||
| JPWO2020167984A5 (https=) |